| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia; , Australia
2 Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia
3 Nephrology, MOnash Medical Centre, Clayton, Victoria, Australia
4 Program in Membrane Biology, Renal Unit, Massachusetts General Hospital, Boston, Massachusetts, United States
* To whom correspondence should be addressed. E-mail: wcomper{at}hotmail.com.
Abstract. The mechanism of albuminuria is perhaps one of the most complex yet important questions in renal physiology today. Recent studies have directly demonstrated that the normal glomerulus filters substantial amounts of albumin and that charge selectivity plays little or no role in preventing this process. This filtered albumin is then processed by proximal tubular cells by two distinct pathways; dysfunction in either one of these pathways gives rise to discrete forms of albuminuria. Most of the filtered albumin is returned to the peritubular blood supply by a retrieval pathway. Albuminuria in the nephrotic range would arise from retrieval pathway dysfunction. The small quantities of filtered albumin that are not retrieved undergo obligatory lysosomal degradation prior to urinary excretion as small peptide fragments. This degradation pathway is sensitive to metabolic factors responsible for hypertrophy and fibrosis, particularly molecules such as angiotensin II and transforming growth factor-β1, whose production is stimulated by hyperglycemic and hypertensive environments. Dysfunction in this degradation pathway leads to albuminuria below the nephrotic range. These new insights into albumin filtration and processing argue for a reassessment of the role of podocytes and the slit diaphragm as major direct determinants governing albuminuria, provide information on how glomerular morphology and tubular albuminuria may be interrelated, and offers a new rationale for drug development.
This article has been cited by other articles:
|
|
 |
|
  A. K. Ahmed, N. S. Kamath, M. El Kossi, and A. M. El Nahas The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease Nephrol. Dial. Transplant., October 10, 2009; (2009) gfp511v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Thrailkill, T. Nimmo, R. C. Bunn, G. E. Cockrell, C. S. Moreau, S. Mackintosh, R. D. Edmondson, and J. L. Fowlkes Microalbuminuria in Type 1 Diabetes Is Associated With Enhanced Excretion of the Endocytic Multiligand Receptors Megalin and Cubilin Diabetes Care, July 1, 2009; 32(7): 1266 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Tanner, C. Rippe, Y. Shao, A. P. Evan, and J. C. Williams Jr. Glomerular permeability to macromolecules in the Necturus kidney Am J Physiol Renal Physiol, June 1, 2009; 296(6): F1269 - F1278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jarad and J. H. Miner Albuminuria, Wherefore Art Thou? J. Am. Soc. Nephrol., March 1, 2009; 20(3): 455 - 457. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
